Investigation of the Effects of Upper Extremity Botulinum Toxin Application on Forearm Muscle Thickness and Motor Recovery in Patients With Hemiplegia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-13

Study Completion Date

2025-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, we aimed to examine the effects of the botulinum toxin (BoNT) application on muscle thickness and motor recovery in stroke patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Botulinum Toxin Applications in Hemiplegic Patients

NCT07240337

Hemiplegia

RECRUITING

The Effect of Ultrasound-Guided Botulinum Toxin Injections on Pain, Functionality, Spasticity, and Range of Motion in Patients With Post-Stroke Upper Extremity Spasticity

NCT05887479

Cerebrovascular Disorders Spasticity, Muscle Botulinum Toxin

WITHDRAWN PHASE4

Muscle Selection for Botulinum Toxin A Injection in Poststroke Elbow Flexor Spasticity

NCT04036981

Muscle Spasticity

COMPLETED

Comparison of Botulinum Toxin Injection Techniques in Spasticity

NCT05615987

Spastic Hemiplegia

UNKNOWN PHASE4

Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral Palsy

NCT06583343

Cerebral Palsy Spastic Diplegia

RECRUITING PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Stroke is the second leading cause of death worldwide. It poses a major risk for disability. Its prevalence is high in developing countries. Spasticity is among the complications of stroke. Excessive spasticity can cause impairments and limitations in patients' motor activity and participation in daily life. Botulinum toxin (BoNT) injection is one of the preferred treatment options. Studies on botulinum toxin administration in stroke patients generally focus on treatment efficacy and motor recovery. Studies examining the effects of botulinum toxin administration on both muscle thickness and motor recovery are few in number. In this study, we aimed to examine the effects of the botulinum toxin (BoNT) application on upper extremity muscle thickness and motor recovery in stroke patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemiplegia Spasticity, Muscle

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Botulinum toxin application

Hemiplegic stroke patients who received upper extremity botulinum toxin will be evaluated retrospectively. Information regarding upper extremity motor recovery, spasticity levels, and muscle thickness measured by ultrasound before and one month after botulinum toxin administration will be obtained from file records.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients must be between the ages of 30-75.
* Patients who received botulinum toxin injection to their upper extremities at least 3 months after a cerebrovascular accident.
* Patients must have had cerebrovascular disease for the first time.

Exclusion Criteria

* Presence of a preexisting musculoskeletal deformity in the upper extremity where botulinum toxin was administered
* Patients with spinal cord injury, multiple sclerosis, and cerebral palsy
* Presence of malignancy.

Minimum Eligible Age

30 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No